Genetic testing identifies germline mutations, while genomic testing analyzes somatic mutations in tumors, influencing treatment options. Broader testing criteria are expanding access to genetic ...

Tens of thousands of patients with lung cancer in the United Kingdom are missing out on targeted treatment that could improve their prognosis due to delays in genomic testing, a new report has warned.

A UCSF study involving 46,000 women suggests a shift from age-based breast cancer screening to personalized risk assessment.

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

A groundbreaking study shows that breast cancer screening works better when it’s personalized. Instead of annual mammograms ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

Genomic testing is pivotal in refining breast cancer treatment strategies, particularly for African American women facing unique diagnostic challenges. Tests like MAMMAPRINT analyze numerous genes, ...

Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center One hundred twenty-two participants completed the survey. The majority ...

Rare inherited genetic variants significantly increase familial lung cancer risk, offering new targets for early detection.

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...